In Vitro Diagnostics Quality Control Market To Forsee Commendable Growth, Due To An Increasing Number Of Accredited Clinical Laboratories

  

 

The global IVD quality control market size is expected to reach USD 1.24 billion by 2026, according to a new report by Grand View Research, Inc. The market is projected to witness a CAGR of 4.1% over the forecast period. Continually evolving technology-oriented changes in the diagnostics field and growing need to ensure patient safety necessitate the implementation of quality assurance programs in various medical disciplines including radiology and Point-of-Care (PoC) devices. Patients rely on self-testing IVD devices for long-term disease management and hence it is important for such devices to be checked, in terms of result reproducibility and validity, to guarantee patient safety.

 

Rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving the market. In addition to quality assessments, amendments to the regulatory framework are made intermittently to enhance the existing standards with the main objective of safeguarding qualitative superiority of the diagnostic services. In May 2016, the European Union passed an agreement to update the pre-existing regulations pertaining to IVD devices, wherein the updates were in concern with raising the patient safety levels, particularly for disabled persons. The presence of third-party agencies for independent assessment of the IVD devices is expected to elevate the current safety standards, which will drive the In Vitro Diagnostics (IVD) Quality Control market further.

 

Further key findings from the study suggest:

• In 2018, the clinical chemistry was the second-largest application segment of the global IVD market, in terms of market share
• Demand for preventive medicine and rapid transformation of clinical laboratories into highly automated and efficient businesses are some of the factors for the segment’s growth
• Molecular diagnostics is projected to be the fastest-growing segment due to increasing technical complexity of molecular diagnostic testing and need for quality evaluation to ensure standards
• These tests are of prime importance as the outcomes enable healthcare practitioners make critical treatment decisions
• Hospitals was the largest segment in 2018 due to the presence of advanced technology-based devices like Next Generation Sequencing (NGS) and microarrays, and rising applications of the optimized quality-control procedures
• North America was the dominant regional market in 2018 due to the presence of over 150,000 registered diagnostics labs and is likely to maintain the dominance throughout the forecast years
• Siemens Healthcare GmbH; Roche Diagnostics; Alere, Inc.; Abbott Laboratories, Inc.; Qiagen N.V.; Bio-Rad Laboratories, Inc.; Quidel Corp.; Becton, Dickinson and Company; bioMerieux, Inc.; Sysmex Corp.; Sero AS; and Thermo Fisher Scientific, Inc. are some of the key companies in the global market

 

The global In Vitro Diagnostics (IVD) and IVD quality control market combines to account for USD 112.79 billion in revenue in 2021, which is expected to reach USD 114.73 billion by 2030, growing at a cumulative rate of 0.2% over the forecast period. The combination bundle is designed to provide a holistic view of these highly dynamic market spaces.

 

In Vitro Diagnostics Quality Control Market Segmentation:

 

Grand View Research has segmented the global IVD quality control market on the basis of application, type, end use, and region:

IVD Quality Control Application Outlook (Revenue, USD Million, 2014 - 2026)

• Immunochemistry
• Hematology
• Clinical Chemistry
• Molecular Diagnostics
• Coagulation
• Microbiology
• Others

 

IVD Quality Control Type Outlook (Revenue, USD Million, 2014 - 2026)

• Quality Control 
  • Quality Controls, by Type
    • Plasma-based Control
    • Serum-based Control
    • Whole Blood-based Control
    • Others
  • Quality Controls, by Application
    • Immunochemistry
    • Hematology
    • Clinical Chemistry
    • Molecular Diagnostics
    • Coagulation
    • Microbiology
    • Others
  • Quality Assurance Services
    • Immunochemistry
    • Hematology
    • Clinical Chemistry
    • Molecular Diagnostics
    • Coagulation
    • Microbiology
    • Others
  • Data Management
    • Clinical Chemistry
    • Immunochemistry
    • Hematology
    • Molecular Diagnostics
    • Coagulation
    • Microbiology
    • Others

 

IVD Quality Control End Use Outlook (Revenue, USD Million, 2014 - 2026)

• Hospitals
• Laboratories
• Home-care
• Others

 

IVD Quality Control Regional Outlook (Revenue, USD Million, 2014 - 2026)

• North America
  • S.
  • Canada
• Europe
  • K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia

 

Order a free sample of this Intelligence study @ https://www.grandviewresearch.com/sector-report/in-vitro-diagnostics-ivd-quality-control-industry-data-book/request/rs1 

 

Wearable Breast Pumps Market To Show Astonishing CAGR, Based On Growing Consumer Awareness Till 2030

 

 

 

The global wearable breast pumps market is anticipated to reach USD 975.5 million by 2030, registering a CAGR of 8.21%, according to a new report by Grand View Research, Inc. Favorable reimbursement policies, and increasing patient disposable income are further anticipated to propel the demand for wearable breast pumps.

 

The decreasing infant mortality rate is supplementing the growth of the market. For instance, according to Knoema, the infant mortality rate in Japan fell from 13.4 deaths per 1,000 births in 1970, to 1.80 deaths in 2019. Similarly, as per Statistics Canada, the infant death rate has fallen from 4.8 per 1,000 in 2018 to 4.5 in 2020 in Canada. Such instances are expected to increase the demand for wearable breast pumps, thereby, propelling the market growth over the forecast period.

 

Increase in women’s employment rate is expected to be a high impact rendering driver of the market. For instance, as per International Labor Organization, the female working population in Australia has touched 60%. Similarly, as per the similar source, the female employment rate in high income countries is estimated to be 53%, whereas, the same in low income and upper middle-income countries is calculated to be 56% and 55% respectively. Working women have a relatively high disposable income, as a result can help the market impel.

 

The presence of various e-commerce sites offering wearable breast pumps will further aid in the sales of the products through these sales channels in the forecast period. Willow, Elvie, Medela, and Amazon, are few prominent e-commerce sites that offers substantial discounts, and prompt customer service on various wearable breast pumps, owing to which individuals prefer to shop from online sites.

 

The decline in the COVID-19 population is anticipated to boost market growth. Recently, many companies have called back their employees to work from office. For instance, companies such as Sun Pharmaceuticals, Biocon, and JP Morgan are planning to start work from office. This will surge the need for wearable breast pumps for working women, thereby propelling the market growth in post-COVID-19 time. Similarly, to cope with the rising demand many companies are launching new products and expanding their geographic presence. For instance, in February 2021, Medela LLC launched a new category expansion and breast care products with an aim of meeting customer requirements. This was expected to expand the customer base of the company.

 

Wearable Breast Pumps Market Report Highlights

• Based on components, the wearable pumps segment dominated the market with a share of 57.84% in 2021 and is also expected to witness the fastest growth rate owing to its increasing demand over the forecast period. As lactating mothers are becoming more aware of the importance and benefits of breastfeeding.
• On the basis of technology, the battery powered wearable breast pump segment dominated the market with a share of 48.64% in 2021. This can be credited to their lightweight and compact designs. Moreover, women can also easily stash them into their bags and are barely noticeable.
• North America dominated the market with the highest revenue share of 52.62% in 2021 owing to a rise in women’s employment rate in the U.S. and supportive reimbursement policies for wearable breast pumps.

 

Breast Pump and Breastfeeding Accessories Market Size was valued at USD 4.06 Billion in 2021 and is projected to expand at a CAGR of 7.8% during 2022 to 2030.

 

Wearable Breast Pumps Market Segmentation

Grand View Research has segmented the global wearable breast pumps market based on component, technology, and region:

 

Global Wearable Breast Pumps Component Outlook (Revenue, USD Million, 2018 - 2030)
• Wearable Pumps
• Accessories

 

Global Wearable Breast Pumps Product Technology Outlook (Revenue, USD Million, 2018 - 2030)
• Manual Wearable Breast Pumps
• Battery Operated Wearable Breast Pumps
• Smart Wearable Breast Pumps

 

Global Wearable Breast Pumps Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
o U.S.
o Canada

• Europe
o U.K.
o Germany
o France
o Italy
o Spain

• Asia Pacific
o Japan
o China
o India
o Australia
o South Korea

• Latin America
o Mexico
o Brazil
o Argentina
o Colombia

• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE

 

Order a free sample of this Breast Pump and Breastfeeding Accessories Industry Data Book @ https://www.grandviewresearch.com/sector-report/breast-pump-breastfeeding-accessories-industry-data-book/request/rs1

 

List of Key Players in Wearable Breast Pumps Market
• Medela AG
• Ameda, Inc.
• Willow Innovations, Inc.
• Philips
• Elvie (Chiaro Component Ltd)
• Freemie
• BabyBuddha Products, LLC
• Spectra
• iAPOY
• Lavie Mom

 

 

In Vitro Diagnostics Market To Rise Up At Exponential Growth, Owing To Development Of Automated IVD Systems For Laboratories And Hospitals

  

 

The global In vitro diagnostics market size is expected to reach USD 113.38 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 0.2% over the forecast period driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

 

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

 

In Vitro Diagnostics Market Report Highlights

• Molecular diagnostics is anticipated to grow at the fastest CAGR from 2022 to 2030 owing to the rising adoption and usage rate
• Reagents held the largest market share owing to the surge in demand for genetic testing and enhanced availability of technologically advanced diagnostic tests in lower and middle-income countries with unmet clinical needs
• The infectious diseases application segment held the largest market share owing to the large volume of testing for infectious diseases globally
• North America dominated the global market in 2021 owing to the high demand for novel technologies, a large pool of key players, high prevalence of diseases, and advanced healthcare infrastructure

 

The global In Vitro Diagnostics (IVD) and IVD quality control markets combine to account for USD 112.79 billion in revenue in 2021, which is expected to reach USD 114.73 billion by 2030, growing at a cumulative rate of 0.2% over the forecast period.

 

In Vitro Diagnostics Market Segmentation

 

Grand View Research has segmented the global in vitro diagnostics market based on product, technology, application, end-use, test location, and region:

 

IVD Product Outlook (Number of Instruments Installed in Thousands, Number of Reagents Sold in Millions; Revenue, USD Million, 2018 - 2030)
• Instruments
• Reagents
• Services

 

IVD Technology Outlook (Number of Instruments Installed in Thousands, Number of Reagents Sold in Millions; Revenue, USD Million, 2018 - 2030)

• Immunoassay
o Instruments
o Reagents
o Services

• Hematology
o Instruments
o Reagents
o Services

• Clinical Chemistry
o Instruments
o Reagents
o Services

• Molecular Diagnostics
o Instruments
o Reagents
o Services

• Coagulation
o Instruments
o Reagents
o Services

• Microbiology
o Instruments
o Reagents
o Services

• Others
o Instruments
o Reagents
o Services

 

IVD Application Outlook (Revenue, USD Million, 2018 - 2030)
• Infectious Disease
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Autoimmune Disease
• Drug Testing
• Others

 

IVD End-use Outlook (Number of Instruments Installed in Thousands, Number of Reagents Sold in Millions; Revenue, USD Million, 2018 - 2030)
• Hospitals
• Laboratories
• Home Care
• Others

 

IVD Test Location Outlook (Revenue, USD Million, 2018 - 2030)
• Point of Care
• Home Care
• Others

 

IVD Regional Outlook (Number of Instruments Installed in Thousands, Number of Reagents Sold in Millions; Revenue, USD Million, 2018 - 2030) 

• North America
  • S.
  • Canada
• Europe
  • K.
  • Germany
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • UAE
  • Saudi Arabia

 

Order a free sample of In Vitro Diagnostics And IVD Quality Control Industry Data Book @  https://www.grandviewresearch.com/sector-report/in-vitro-diagnostics-ivd-quality-control-industry-data-book/request/rs1

 

List of Key Players in In Vitro Diagnostics Market
• Abbott
• Bio-Rad Laboratories, Inc.
• Quest Diagnostics
• bioMérieux SA
• QIAGEN
• Sysmex Corp.
• Agilent Technologies

 

 

Breast Pump Market To Predict Global Expansion, Based On Rising Women's Employment Rates To 2030

 

 

 

The global breast pump market is expected to reach USD 5.20 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 8.3% from 2022 to 2030. Improving healthcare infrastructure in emerging economies, increasing global women's employment rates and the presence of favorable demographics are the key driving factors for the breast pump market. 

Moreover, the market has seen significant growth over the last few decades, owing to increasing product launches by key players, and rising R&D activities. For instance, in March 2021, the Philips Avent Double Electric Breast Pump, Advanced is the top brand of mothers and children care goods recommended by pregnant women and mothers in the U. S. It features Natural Action technology, a powerful combination of suction and nipple stimulation that simulates the distinctive wave-like tongue motion that occurs when the baby sucks. This technology initiates the milk flow faster than previous models, enabling moms to express their milk more effectively.

Similarly, in October 2021, Willow also launched its Perfect Pumping Bra, developed by The Dairy Fairy. Willow pump bra was designed to provide moms with exceptional comfort, support, and a perfect fit, helping them to have the best possible pumping experience. The appropriate fit can help boost the mother's milk flow while using wearable breast pumps. Adjustable straps, a customizable mesh panel, beautiful lace embellishments, and a patent-pending double extender clip characterize the Willow Perfect Pumping Bra. Furthermore, the wire-free bra's luxurious fabric is machine washable and elastic while still being designed to secure the Willow pump for an ideal pumping experience. As a result, product launches with additional benefits are expected to increase market growth for these breast pumps over the projection period.

 

Breast Pump Market Report Highlights: 

• In terms of product, closed system segment held the largest market share of 65.3% in 2021 and is expected to witness the fastest growth over the forecast period due to its several benefits and high adoption, as compared to the open system. 

• In terms of technology, electric pumps segment held the largest share in 2021 owing to its flexibility and ease of use. 

• In terms of application, hospital grade segment held the largest market share in 2021, owing to the increasing number of hospitals and rising healthcare expenditure. 

• North America is expected to dominate the market growth over the forecast period owing to the rising women's employment and large presence of key players operating in the market.  

Breast Pump and Breastfeeding Accessories Market Size was valued at USD 4.06 Billion in 2021 and is projected to expand at a CAGR of 7.8% during 2022 to 2030. 

 

Breast Pump Market Segmentation

 

Grand View Research has segmented the global breast pump market report on the basis of product, technology, application, and region:

 

Breast Pump Market - Product Outlook (Revenue, USD Million, 2018 - 2030) 

• Open System
• Closed System

 

Breast Pump Market - Technology Outlook (Revenue, USD Million, 2018 - 2030) 

• Manual Pumps
• Battery Powered Pumps
• Electric Pumps

 

Breast Pump Market - Application Outlook (Revenue, USD Million, 2018 - 2030) 

• Personal Use
• Hospital Grade

 

Breast Pump Market - Regional Outlook (Revenue, USD Million, 2018 - 2030) 

• North America
  • S.
  • Canada
• Europe
  • K.
  • Germany
  • France
  • Italy
  • Spain
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

 

List of Key Players in Breast Pump Market 

• Ameda (Magento, Inc.)
• Hygeia Health
• Medela AG
• Koninklijke Philips N.V.
• Lansinoh Laboratories, Inc.
• Pigeon Corporation
• Motif Medical
• Chiaro Technology Limited (Elvie)
• Willow Innovations, Inc.
• Spectra Baby USA 

 

Request free sample copy of Breast Pump and Breastfeeding Accessories Industry Data Book @  https://www.grandviewresearch.com/sector-report/breast-pump-breastfeeding-accessories-industry-data-book/request/rs1